 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Over the last three days, A.I.dvisor has detected that RENB's AroonUp green line (see chart) is above 70, while the AroonDown red line is below 30. When the green line goes above 70 while the red...

Renovaro Biosciences (RENB, $4.46) Aroon Indicator entered an Uptrend on September 29, 2023.

This is a Bullish indicator signaling RENB's price could rise from here. Traders may explore going long the stock or buying call options...

Renovaro Biosciences (RENB, $4.07) Moving Average Convergence Divergence (MACD) Histogram turned positive on September 28, 2023

Renovaro Biosciences (RENB, $4.07) Aroon Indicator entered an Uptrend on September 28, 2023.

This is a signal that RENB's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...

Renovaro Biosciences (RENB, $4.07) RSI Indicator left the overbought zone on September 28, 2023

NEW YORK, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates APRN, RENB, FNCB

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates APRN, RENB, TALS, WMC SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates APRN, RENB, TALS, WMC PR Newswire NEW YORK, Sept. 29, 2023 NEW...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates APRN, RENB, TALS, WMC

Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Renovaro Biosciences Inc. (NASDAQ: RENB) and GEDi Cube Intl Ltd. is fair to Renovaro shareholders. Under the...

RENB Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Renovaro Biosciences Inc. Is Fair to Shareholders

GEDi Cube Intl Ltd. (GEDi Cube), an AI medical technology company, and Renovaro Biosciences Inc. (NASDAQ:RENB) (Renovaro), an advanced, preclinical biotechnology firm in cell, gene and immunotherapy...

GEDi Cube and Renovaro Biosciences Sign Definitive Agreement to Combine

The combined company aims to accelerate precision, personalized medicine for longevity powered by mutually reinforcing AI and biotechnology platforms for early diagnosis, better targeted treatments...

Renovaro Biosciences and AI Health Company GEDi Cube Sign Definitive Agreement to Combine

Renovaro Biosciences (RENB, $3.8) Aroon Indicator entered an Uptrend on September 27, 2023.

Renovaro Biosciences, Inc. is a pre-clinical stage biotechnology company, which engages in the development of genetically modified cellular and immune-therapy technologies used for the treatment of infectious diseases and cancer. Its pipeline consists of ENOB-HV-01, ENOB- HV-11, ENOB-HV-12, ENOB-DB-01, ENOB-DC-01, ENOB-DC-11, and ENOB-DC-21. The company was founded by Rene Sindlev and Serhat Gumrukcu on January 18, 2011 and is headquartered in Los Angeles, CA.

Watchers	2,775
52-Wk Low	$0.3928
52-Wk High	$4.50

Market Cap	$260.53M
Volume (M)	471,024.00
52-Wk High	$4.50
52-Wk Low	$0.3928

RENB Enochian Biosciences Inc

About

Feed

News

Sentiment

Fundamentals